Built together, across Europe.

4P-CAN is a Horizon Europe-funded project that aims to understand barriers, whether legislative, socio-economic, commercial, or behavioural to the widespread adoption of cancer primary prevention measures across Central and Eastern Europe.

All.Can International is a global multi-stakeholder network dedicated to improving cancer care efficiency and enhancing health outcomes for patients worldwide—from prevention to post-treatment quality of life. The organisation advances this mission by generating, promoting and advocating for evidence-based and measurable improvements in cancer care research, policy and practice.

Anticancer Fund is an independent non-profit organisation dedicated to helping people with cancer live longer, better lives by turning evidence into care. We fund innovative clinical trials, including research into new uses for existing treatments; provide free, personalised, science-based information through My Cancer Navigator; and advocate for patient-centred cancer policies at European level. By making reliable information clear and accessible, we help people participate more confidently in decisions about their care.

PREVIA is a Romanian nonprofit organisation dedicated to cancer prevention, patients’ rights, and support for people affected by cancer and their families. Founded by a cervical cancer survivor, PREVIA brings lived experience into education and advocacy. Through awareness campaigns, community events, and partnerships, we promote HPV vaccination, cervical screening, and access to clear, reliable health information. We empower people to make informed decisions and help ensure patients’ voices are heard.

EVITA is a Portugal-based association supporting people and families affected by hereditary cancer since 2011. We offer direct support, help improve hereditary cancer literacy, and are committed to advancing prevention and early detection of hereditary cancer, from research to policy.

Astra Forum Foundation is a Bulgarian non-profit organisation with a broad network of healthcare professionals and experience in health literacy initiatives. It has also been involved in supporting healthcare integration for refugees in Bulgaria.

The Bulgarian Joint Cancer Network (BJCN) is a national multi-stakeholder cluster dedicated to advancing sustainable system solutions and modern cancer policy through innovation, scientific integrity, and coordinated cross-sector collaboration. Bringing together clinicians, researchers, patient organizations, institutions, and technology innovators, BJCN’s mission is to build a resilient, equitable, and future-ready oncology system by aligning with European standards and accelerating the adoption of transformative tools — from guideline development, continuous medical education, and quality-of-care indicators to digital health and AI-enabled decision-support systems. Through structured networking, shared expertise, and mission-driven policy coordination, BJCN works to shape a sustainable, integrated oncology ecosystem that delivers measurable value for patients and strengthens the national health system, culminating in the co-creation of the National Cancer Mission Hub

CAREWAY aims to improve cancer literacy and reduce inequalities in cancer prevention, diagnosis, and care. It aims to make reliable health information accessible to everyone, especially individuals and communities with limited health or digital literacy.

INOMED is a not-for-profit organisation based in Bucharest, Romania, with interest in 4P-Medicine, innovative health policies, innovative communication, and social innovation. INOMED is deeply involved in the implementation of the Europe’s Beating Cancer Plan and Cancer Mission at European, National and local level. Since its establishment, INOMED has worked at the intersection of innovation, policy, and communication, with a strong focus on enabling access to cutting-edge advances in areas such as personalised (precision) medicine, genomics and multi-omics, digital health, oncology, biotechnology, and systems biology. By creating platforms for dialogue, education, and advocacy, INOMED has contributed to shaping a more informed and innovation-ready healthcare ecosystem.

CLEAR-PC is a European initiative aimed at improving health and digital health literacy related to prostate cancer. The project explores what men know about prostate cancer prevention, early detection and care, and identifies barriers affecting informed and shared decision-making. Through surveys, focus groups, stakeholder engagement and co-creation activities, CLEAR-PC will develop accessible, evidence-based resources tailored to diverse populations, particularly vulnerable groups. Its ultimate goal is to support equitable access to reliable information and help men make informed health decisions confidently.

Dnipro State Medical University (DSMU) is one of the leading medical higher education institutions in Ukraine. The university has 5 faculties and 55 departments of basic and clinical sciences, 41 of which are located in the hospitals of Dnipro city.

ECHoS is an European project, funded by Horizon Europe Programme, that aims to support the implementation of the Cancer Mission activities in all Member State and Associated Country (MS/AC) through the establishment and development of National Cancer Mission Hubs (NCMHs) operating at national, regional, and local levels.

Euro Comunicare is a Romanian NGO that specialises in strategic communication, media literacy, and disinformation analysis.

Europa Donna Serbia - The Serbian Breast Cancer Forum is a non-governmental, non-profit organization founded in 2016 that has been advocating for improved breast cancer care and quality of life for people affected by breast cancer in Serbia. Its activities focus on patient advocacy, access to quality healthcare, health and cancer literacy, and raising awareness of prevention, screening and early detection. Europa Donna Serbia is a member of Europa Donna - The European Breast Cancer Coalition and the organization behind OncoGuide: Breast Cancer Serbia, a free bilingual digital resource available in Serbian and English at rak-dojke.com.

European Network for Smoking and Tobacco Prevention (ENSP) is an organisation dedicated to reducing tobacco use and its associated health risks across Europe. ENSP represents a wide coalition of public health advocates, medical professionals, research institutions, and civil society groups.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is located in Rome and is one of Italy’s leading hospitals. It provides health services in all clinical and surgical areas and is recognised as a leading oncology hospital, with more than 40,000 services provided annually. It is also a Reference Center in the Lazio Region for many high-complexity diseases, both in children and adults.

The General Directorate of Medical and Social Assistance is a subdivision of the municipal public administration Chisinau, Moldova. The Directorate serves a population of approximately 1 million residents in the capital city of the Republic of Moldova. Its mission is to implement health and social policies, promote disease prevention and health literacy, provide social assistance, ensure public health and welfare, and improve the quality of life of individuals and families through the implementation of national and municipal policies, strategies, and programs in the fields of health and social assistance.

Global Health Connector connects 78 Countries and 4.4 billion people. As a member organisation, Global Health Connector brings its global community together in a network of ecosystems that match needs and solutions, break down silos, transform healthcare, transfer best practices and lessons learned and create economic opportunities.

INOC – Istituto Nazionale Oncologico Candiolo is a leading center dedicated to the diagnosis, treatment, and research of oncological diseases. Established in 1996 through the commitment of the Fondazione Allegra Agnelli, it has grown into a nationally and internationally recognized center of excellence. Since 2013, as an IRCCS (Institute for Research, Hospitalization and Healthcare), INOC has integrated clinical care and scientific research to develop increasingly effective, personalized treatments. INOC is part of the Piedmont and Aosta Valley Oncology Network and the Alliance Against Cancer (ACC), and is a Full Member of the European Organization of Cancer Institutes (OECI), recognized as a Comprehensive Cancer Centre. At European level, INOC is also a member of EUNetCCC, the European Network of Comprehensive Cancer Centres, contributing to the development of integrated and equitable cancer care across Europe. Every year, INOC provides care to more than 37,000 patients through personalized treatment pathways in both day hospital and inpatient settings. Its commitment to excellence combines advanced technologies, innovative procedures, multidisciplinary expertise, research, and continuous professional development, with the goal of placing patients at the center and advancing cancer care.

The Jean Monnet Centre of Excellence (JMCE-PU) is a research unit at Paisii Hilendarski University of Plovdiv. It promotes collaboration among academic institutions, public bodies, and civil society, with a focus on risk communication, public understanding of science and technology, and European integration.

MAYA is a Horizon Europe-funded project empowering young cancer survivors to take control of their cardiovascular health through AI-driven, personalised care

Montenegrin Association of Medical Oncologists (CUMO) focuses on health literacy and patient engagement, particularly within rural and vulnerable communities. It has a history of working with marginalised groups such as the elderly, Roma populations, and individuals living with HIV.

The Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA) is Portugal’s leading public health institution, dedicated to the advancement of public health, disease prevention, and research excellence. INSA is a central pillar in Portugal’s healthcare system, conducting vital research across a broad spectrum of health sciences, including epidemiology, environmental health, and genomics.

PHOENIX is a Horizon Europe Cancer Mission project dedicated to improving treatment options for children and adolescents with relapsed or treatment-resistant solid tumours. While survival rates for childhood cancer have increased considerably over recent decades, patients with high-risk cancers continue to face limited therapeutic options, and current treatments often result in severe long-term side effects that affect their quality of life well into adulthood. To address this unmet medical need, PHOENIX will conduct the first international Phase I/II clinical trial evaluating ibrilatazar, an innovative anticancer drug with the potential to provide a safer therapeutic approach by selectively targeting tumour cells while reducing damage to healthy tissues. Beyond the clinical trial, the project integrates biomarker discovery, liquid biopsy technologies and personalised medicine to better predict treatment response and support more precise clinical decision-making. By bringing together leading clinical, scientific and communication partners, PHOENIX aims to generate the evidence needed to improve survival, reduce treatment-related toxicity and contribute to a new generation of personalised therapies for children with cancer.

PredictAYA is a Horizon Europe-funded project that aims to predict and prevent late effects in adolescent and young adult cancer survivors, with a focus on fertility and reproductive health.

Raportuldegarda.ro is a Romanian medical communication and information platform established in 2017 by the Centre for Innovation in Medicine. Born from a medical communication training programme, Raportuldegarda.ro has grown over nearly a decade into an established source of information on medicine, biomedical research and healthcare innovation. From the beginning, it has placed particular emphasis on emerging areas of medicine and was among the first platforms in Romania to cover gene and cell therapies. Nearly a decade after its launch, Raportuldegarda.ro continues to evolve while remaining committed to credible medical information, editorial rigor and meaningful communication about innovation in health.

SHINE 2Europe is a Portuguese SME dedicated to promoting inclusive communities for all citizens by delivering research services and supporting the implementation of tech-savvy, healthy, and inclusive solutions across Europe, with a clear vision of fostering societal growth and inclusiveness.

Through its OncoOmix programme, STaiMIC is not only busy developing clinical descion-support AI-powered tools, but also focuses on AI literacy in cancer care, supporting both cancer-facing healthcare professionals and patients through distinct, audience-tailored approaches. We help clinicians critically understand and communicate AI-supported evidence, while helping patients navigate increasingly complex AI and cancer precision-medicine concepts with clarity, confidence and realistic expectations.

The Informed Patient (TIP) is an evidence-based, guideline-led cancer health-literacy platform, co-created with patients. We provide personalised, longitudinal support that helps people understand and engage with their own cancer information over time. TIP combines accessible, tailored information with validated health-literacy approaches and responsible use of AI. We have a particular focus on reducing inequalities and supporting underserved populations. We are developing feasibility studies with NHS cancer centres and are keen to contribute to European collaboration, research and shared learning in cancer literacy

CINTESIS (University of Aveiro) is a multidisciplinary research unit focusing on clinical and quality of life research for cancer survivors, psychosocial rehabilitation, and self-care. Its collaborative network spans 46 partner institutions and 8 higher education hubs.